![David Arkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Arkowitz
Directeur/Membre du Conseil chez
IBIO, INC.
Fortune : 34 926 $ au 31/05/2026
Profil
David A. Arkowitz is currently Director at Yumanity, Inc., Independent Director at iBio, Inc. since 2024, and Chief Financial Officer at Alkeus Pharmaceuticals, Inc. since 2024.
Former positions include Director at ImpactRx, Inc. (2009), Director at Aegerion Pharmaceuticals, Inc. (2009), Director-Financial Planning & Analysis at Merck-Medco Managed Care LLC, Independent Director at Proteostasis Therapeutics, Inc., Independent Director at F-Star Therapeutics, Inc. (2020–2023), Independent Director at Kineta, Inc. (2022–2025), Independent Director at Yumanity Therapeutics, Inc. (2020–2022), VP & Controller-Research & Development Division at Merck & Co., Inc. (2003), Chief Financial Officer & Treasurer at Idenix Pharmaceuticals LLC (2003–2007), Chief Financial Officer & General Manager at Mascoma Corp.
(2011–2013), Chief Financial & Accounting Officer at Flexion Therapeutics, Inc. (2018–2021), Vice President-Finance & Business Development at Merck Frosst Canada Ltd. (2000),.
Controller at Merck Research Laboratories Massachusetts LLC (1990–2003), Chief Financial & Business Officer at AMAG Pharmaceuticals, Inc. (2007–2011), CFO, Executive VP & Head-Business Development at Seres Therapeutics, Inc. (2021–2024), and Chief Operating & Financial Officer at Visterra, Inc. (2013–2018).
Education includes undergraduate studies at Brandeis University and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IBIO, INC. 0,05% | 20/11/2025 | 18 382 ( 0,05% ) | 34 926 $ | 31/05/2026 |
Postes actifs de David Arkowitz
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 25/11/2024 |
Alkeus Pharmaceuticals, Inc.
 Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Directeur Financier/CFO | 01/10/2024 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Directeur/Membre du Conseil | - |
Anciens postes connus de David Arkowitz
| Sociétés | Poste | Fin |
|---|---|---|
| KINETA, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| SERES THERAPEUTICS, INC. | Directeur Financier/CFO | 15/03/2024 |
| F-STAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/03/2023 |
| YUMANITY THERAPEUTICS | Directeur/Membre du Conseil | 01/12/2022 |
| FLEXION THERAPEUTICS, INC. | Directeur Financier/CFO | 31/05/2021 |
Formation de David Arkowitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health-care sector custom research and promotional consultancy services | Commercial Services |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Develops technology for abundant biomass conversion | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Health Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
